Menu Search
Equities

Extendicare Inc

  • Add to watchlist
  • Add to portfolio
  • Add an alert
5XE:STU

Extendicare Inc

Actions
  • Price (EUR)14.70
  • Today's Change0.00 / 0.00%
  • Shares traded0.00
  • 1 Year change+98.65%
  • Beta1.1356
Data delayed at least 15 minutes, as of Feb 06 2026.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Extendicare Inc. is a provider of care and services for seniors across Canada. The Company operates under the Extendicare, ParaMed, Extendicare Assist, and SGP Purchasing Network brands. The Company operates a network of approximately 99 long-term care homes (59 owned, 40 under management contracts), delivers approximately 11.2 million hours of home health care services annually, and provides group purchasing services to third parties representing approximately 148,200 beds across Canada. Its segments include Long-term Care, Home Health Care, and Managed Services. The Company provides home healthcare services through ParaMed, which is engaged in providing complex nursing care, occupational, physical and speech therapy and assistance with daily activities to accommodate clients of all ages living at home. Its Managed Services segment includes its management contracts and consulting and other services, and group purchasing services.

  • Revenue in CAD (TTM)1.59bn
  • Net income in CAD91.01m
  • Incorporated2012
  • Employees24.00k
  • Location
    Extendicare Inc3000 Steeles Avenue East, Suite 400MARKHAM L3R 4T9CanadaCAN
  • Phone+1 (905) 470-4000
  • Fax+1 (905) 470-5588
  • Websitehttps://www.extendicare.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.